NCT05484934RecruitingNot Applicable
Open Label Case Reports Investigating Wound Healing, Aesthetic Outcomes, and Patient Satisfaction Following Nipple-Areolar Complex (NAC) Reconstruction Using a Decellularized Donor NAC Graft (DCLNAC)
BioAesthetics2 sites in 1 country36 target enrollmentStarted: September 21, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 36
- Locations
- 2
- Primary Endpoint
- Healing of the nipple (VAS=Visual Analog Scale) granulation
Study Overview
Brief Summary
To evaluate the wound healing response following nipple-areolar complex (NAC) reconstruction with a decellularized donor NAC graft (DCLNAC)
Detailed Description
Primary Objective
• To evaluate the wound healing response following nipple-areolar complex (NAC) reconstruction with a decellularized donor NAC graft (DCLNAC).
Secondary Objectives
- To evaluate nipple dimensions and vascularization up to 12 months following nipple reconstruction using DCLNAC.
- To evaluate patient satisfaction and well-being up to 12 months following nipple reconstruction using DCLNAC.
Exploratory Objectives
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •General Criteria:
- •Females age >18 and <65 years old. Women of childbearing potential must agree to use an acceptable method of contraception for one month prior to DCLNAC implantation, and until the graft is 100% healed. Acceptable forms of birth control include abstinence, birth control pills, or any double combination of: intrauterine device (IUD), male or female condom, diaphragm, sponge, and cervical cap. Nonchildbearing potential for women is defined as postmenopausal (last natural menses greater than 12 months) or undergone a documented bilateral tubal ligation or hysterectomy. If last natural menses less than 12 months, a serum FSH value confirming post-menopausal status can be employed.
- •Patient agrees to sleep on back until study tissue products are healed
- •Patient agrees to abstain from aspirin, alcohol, or excessive caffeine until study tissue products are healed
- •Patient agrees to not undergo NAC tattooing until completing study
- •Patient can understand and willing to sign informed consent
- •Patient desires bilateral nipple reconstruction with DCLNAC
- •Subjects must be capable of providing written informed consent to the study procedures and for use of protected health information [Health Insurance Portability and Accountability Act (HIPAA), if applicable]
- •Specific Criteria
- •Patient had a bilateral mastectomy with no radiation therapy
- •Patient has undergone a bilateral autologous breast reconstruction a minimum of 3 months prior to enrolling in the study
- •Patient had a unilateral mastectomy with no radiation therapy
- •Patient has undergone a unilateral autologous breast reconstruction a minimum of 3 months prior to enrolling in the study
- •Patient had a bilateral mastectomy and received radiation unilaterally
- •Patient has undergone a bilateral autologous breast reconstruction a minimum of 3 months prior to enrolling in the study
- •Patient had unilateral or bilateral mastopexy (with or without augmentation) or reduction mammaplasty and suffered nipple complications (i.e., necrosis, projection loss)
- •Patient had unilateral or bilateral mastectomy
- •Patient had unilateral or bilateral autologous breast reconstruction a minimum of 3 months prior to enrolling in the study
- •Patient did not receive radiation to the autologously reconstructed breast
- •Patient had unilateral or bilateral nipple reconstruction that failed (i.e., necrosis, projection loss)
- •Implant based reconstruction
Exclusion Criteria
- •Patient has a history of delayed wound healing
- •Patient has a history of Vitamin C deficiency
- •BMI<18.5 or >40 kg/m2
- •Patient has a history of allergic reaction to any decellularized biologic matrix product
- •Patient is currently smoking or using tobacco or nicotine products (i.e., patch, gum, vaping or nasal spray) or has used such products in the past 6 months
- •Patient is currently receiving bilateral breast radiation or completed less than 3 months prior to screening
- •Patient has any systemic disease that would impede wound healing, such as diabetes or connective tissue disorders
- •Patient is pregnant, breastfeeding or planning to become pregnant during the study period
- •Patient has any type of disease or disorder that in the investigator's opinion would make the patient unfit for the study, including active infection anywhere in the body.
- •Acute mastitis in either breast
- •History of an autoimmune disorder
- •Use of any medications currently or in the past 3 months that would impair wound healing, such as long-term use of systemic steroids (inhaled, limited topical, short-term oral use and intra-articular steroids are acceptable)
Outcomes
Primary Outcomes
Healing of the nipple (VAS=Visual Analog Scale) granulation
Time Frame: 3 months
granulation (0-100% VAS)
Time to complete healing (graft >99% re-epithelialized)
Time Frame: 3 months
To evaluate the time to complete healing following NAC reconstruction with DCLNAC.
Healing of the nipple (infection) A. no infection B. hyperemia (no infection) C. cellulitis (superficial infection D. abscess or purulent infection
Time Frame: 3 months
As above
Healing of the nipple (VAS=Visual Analog Scale) ischemia/necrosis
Time Frame: 3 months
ischemia/necrosis (0-100% VAS)
Healing of the nipple (VAS=Visual Analog Scale) overall healing
Time Frame: 3 months
overall healing (0-100% VAS)
Healing of the nipple (VAS=Visual Analog Scale) epithelialization
Time Frame: 3 months
epithelialization (0-100% VAS)
Healing of the nipple (VAS=Visual Analog Scale) dehiscence
Time Frame: 3 months
dehiscence (0-100% VAS)
Secondary Outcomes
- Nipple projection(12 months)
- Vascularization by presence of bleeding(12 months)
- Evaluate patient satisfaction and well-being preoperatively and serially(12 months)
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Not yet recruiting
Not Applicable
Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal ConditionsOsteoarthritisTendinitisDegenerative ArthritisLigament InjuryNeuropathyPelvic PainSports InjuryDegenerative Disc DiseaseNCT03390920R3 Stem Cell200
Completed
Not Applicable
Evaluation of Negative Pressure Wound Therapy in the Treatment of DFUs Incl. Post Amputation Wounds.Foot UlcersDiabetesNCT01011387Molnlycke Health Care AB16
Terminated
Phase 4
Repair of Challenging Abdominal Wall Defects: Strattice(TM) TM in Abdominal Wall Repair (StAR)Surgical Wound DehiscenceHerniaNCT01083472LifeCell37
Unknown
Not Applicable
Study of Amniotic Membrane Graft in the Management of Diabetic Foot UlcersDiabetic FootFoot Ulcer DiabeticNCT02399826Lower Extremity Institute for Research and Therapy40
Completed
Not Applicable
Clinical Evaluation of Postoperative Healing After Conventional And Laser Assisted Frenectomy OperationsHypertrophy, Lip FrenulumNCT03552809Marmara University48